← Evidence map

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2022

End Points for Clinical Trials in Hyperoxaluria: Case Study of Patient-Focused Drug Development in a Rare Disease.

John C Lieske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34634431